Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models.
Gonzalo Rodriguez-BerrigueteMarco RanzaniRemko PrevoRathi PuliyadiNicole D MachadoHannah R BollandVal MillarDaniel V EbnerMarie BoursierAurora CeruttiAlessandro CicconiAlessandro GalbiatiDiego GrandeVera GrinkevichJayesh MajithiyaDesiree PiscitelloEeson RajendraMartin StockleySimon J BoultonEva-Leonne GöttgensRobert A HealdGraeme C M SmithHelen M R RobinsonGeoff S HigginsPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These results pave the way for future clinical trials of Polθ inhibitors in combination with radiotherapy.